嘉实中证医疗ETF发起联接C(014603)财务指标
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 本期已实现收益 |
-1,382,162.82 |
-16,215,994.97 |
-15,208,236.00 |
-59,235,215.14 |
| 本期利润 |
-18,366,206.51 |
15,316,281.33 |
5,700,562.90 |
-54,762,850.29 |
| 加权平均基金份额本期利润 |
-0.06 |
0.05 |
0.02 |
-0.13 |
| 本期加权平均净值利润率(%) |
-9.84 |
8.10 |
2.74 |
-23.70 |
| 本期基金份额净值增长率(%) |
-8.30 |
5.25 |
1.78 |
-17.01 |
| 期末可供分配利润 |
-160,573,861.59 |
-117,178,618.86 |
-155,428,122.03 |
-180,401,622.09 |
| 期末可供分配基金份额利润 |
-0.47 |
-0.42 |
-0.44 |
-0.45 |
| 期末基金资产净值 |
181,931,732.70 |
161,341,149.52 |
198,013,341.46 |
220,804,211.72 |
| 期末基金份额净值 |
0.53 |
0.58 |
0.56 |
0.55 |
| 基金份额累计净值增长率(%) |
-46.88 |
-42.07 |
-43.98 |
-44.96 |
微信公众号
证券之星APP
基本资料
